TY - JOUR
KW - Case–control study
KW - Diabetes mellitus type 2
KW - Glycemic control
KW - HbA1c
KW - Sex
KW - Vte
KW - Venous thromboembolism
AU - Charlier SH
AU - C. Meier
AU - S. Jick
AU - C. Meier
AU - C. Becker
AD - Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Spitalstrasse 26, 4056, Basel, Switzerland.
Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
Division of Endocrinology, Diabetes & Metabolism, University Hospital Basel, Basel, Switzerland.
Boston Collaborative Drug Surveillance Program, Lexington, USA.
School of Public Health, Boston University, Boston University School of Medicine, Lexington, USA.
Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Spitalstrasse 26, 4056, Basel, Switzerland. christoph.meier@unibas.ch.
Hospital Pharmacy, University Hospital Basel, Basel, Switzerland. christoph.meier@unibas.ch.
Boston Collaborative Drug Surveillance Program, Lexington, USA. christoph.meier@unibas.ch.
AN - 34983504
BT - Cardiovasc Diabetol
C2 - PMC8729078
DO - 10.1186/s12933-021-01432-1
DP - NLM
ET - 2022/01/06
LA - eng
M1 - 1
N1 - 1475-2840
R Charlier, Sarah H
Meier, Christian
Jick, Susan S
Meier, Christoph R
Becker, Claudia
Journal Article
Cardiovasc Diabetol. 2022 Jan 4;21(1):2. doi: 10.1186/s12933-021-01432-1.
PY - 2022
SN - 1475-2840
EP - 2
T2 - Cardiovasc Diabetol
TI - Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study
VL - 21
ER -